Relationship between treatment modalities, glycemic control, and diabetes complications with risk of depression and anxiety in type 2 diabetes mellitus patients
Serkan Günalay1, Emin Taşkıran2, Bilgin Demir3, Semiha Erdem2, Haluk Mergen1, Harun Akar2
1İzmir Tepecik Eğitim ve Araştırma Hastanesi, Aile Hekimliği Kliniği, İzmir, Türkiye
2İzmir Tepecik Eğitim ve Araştırma Hastanesi, İç Hastalıkları Kliniği, İzmir, Türkiye
3İzmir Foça Devlet Hastanesi, İç Hastalıkları Kliniği, İzmir, Türkiye
Keywords: Anxiety; depression; diabetes mellitus; hospital anxiety and depression scale.
Objectives: This study aims to determine the risks of depression and anxiety and the correlation between performed treatment modalities and risk of depression and anxiety in type-2 diabetes mellitus (DM) patients.
Materials and methods: A total of 128 patients (58 males, 70 females; mean age 60±10.8 years; range 30 to 80 years) followed-up with the diagnosis of DM were included in the study. The patients were performed a questionnaire inquiring their socio-demographic properties, hospital anxiety and depression scale, and utilized treatment modalities for DM. Patients’ height, weight, and glycated hemoglobin values were recorded.
Results: Mean scores of hospital anxiety and depression scale-anxiety minor scale (HAD-A) and hospital anxiety and depression scale-depression minor scale (HAD-D) were 7.52±4.6 and 7.98±4.4, respectively. A total of 39 and 63 patients exceeded threshold score in HAD-A and HAD-D, respectively. Mean anxiety score was higher among patients who were only treated with insulin compared to those treated with oral antidiabetics or both insulin and oral antidiabetics. Anxiety risk was higher among patients who had experienced previous hyperglycemic acute complications compared to those who had not.
Conclusion: Our study revealed the importance of psychiatric assistance in management of type 2 DM patients beyond conventional follow-up.